Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
7
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Liver Steatosis in Pediatric CD Patients
Role: collaborator
SGLT-2 Inhibitors in the Treatment of Ascites
Role: collaborator
Implementing Dynamic Consent for Rare Disease Patients
Role: collaborator
Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma
Role: collaborator
ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19
Role: collaborator
Hepatitis C Virus Infection in Patients With Hemoglobinopathies
Role: collaborator
Antenatal Diagnosis of Placental Attachment Disorders
Role: collaborator
All 7 trials loaded